Table 2 Summative demographic data and clinical features of patients of LDLT who underwent RYHJ
Median (range) | ||
|---|---|---|
Recipient age (years) | 50.5 (39–71) | |
MELD score | 13 (6–28) | |
Cold ischemia time (min) | 84.5 (23–155) | |
Warm ischemia time (min) | 18 (1–38) | |
Anhepatic phase time(min) | 28 (15–100) | |
Transplantation operative time (min) | 360 (180–540) | |
Transplantation blood loss (ml) | 2650 (600–8000) | |
Hepaticojejunostomy operative time (min) | 260 (180–530) | |
Hepaticojejunostomy blood loss (ml) | 300 (100–7000) | |
Time from RL-LDLT to RYHJ (month) | 23.5 (0–58) | |
No. | (%) | |
Gender | ||
Male | 18 | 81.8 |
Female | 4 | 18.2 |
Bile leak | ||
Yes | 12 | 54.5 |
No | 10 | 45.5 |
No. of bile duct orifice | ||
1 | 14 | 63.6 |
2 | 7 | 31.8 |
3 | 1 | 4.5 |
Type of bile duct anastomosis | ||
D-G | 12 | 54.5 |
D-D | 10 | 45.5 |
T-tube placement | ||
Yes | 5 | 22.7 |
No | 17 | 77.3 |
Hepatic artery complications | ||
Yes | 3 | 13.6 |
No | 19 | 86.4 |
IHD stone | ||
Yes | 14 | 63.6 |
No | 8 | 36.4 |
ABO incompatibility | ||
Yes | 4 | 18.2 |
No | 18 | 81.8 |
Rejection | ||
Yes | 8 | 36.4 |
No | 14 | 63.6 |
Survival | ||
Alive | 14 | 63.6 |
Death | 8 | 36.4 |